34.56
Vericel Corp stock is traded at $34.56, with a volume of 59,346.
It is down -1.23% in the last 24 hours and up +6.74% over the past month.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
See More
Previous Close:
$35.06
Open:
$34.88
24h Volume:
59,346
Relative Volume:
0.09
Market Cap:
$1.75B
Revenue:
$249.12M
Net Income/Loss:
$7.11M
P/E Ratio:
277.37
EPS:
0.1246
Net Cash Flow:
$-8.30M
1W Performance:
-5.05%
1M Performance:
+6.74%
6M Performance:
-11.10%
1Y Performance:
-21.28%
Vericel Corp Stock (VCEL) Company Profile
Name
Vericel Corp
Sector
Industry
Phone
(734) 930-5555
Address
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
VCEL
Vericel Corp
|
34.66 | 1.77B | 249.12M | 7.11M | -8.30M | 0.1246 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.97 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
632.67 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.39 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.90 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.94 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-09-24 | Initiated | Canaccord Genuity | Buy |
| Jun-20-24 | Initiated | TD Cowen | Buy |
| Jan-25-24 | Upgrade | Truist | Hold → Buy |
| Aug-08-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-09-22 | Downgrade | Truist | Buy → Hold |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Jan-11-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Initiated | Stephens | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Oct-09-19 | Initiated | H.C. Wainwright | Buy |
| Feb-28-19 | Downgrade | Needham | Buy → Hold |
| Aug-08-18 | Reiterated | Needham | Buy |
| Jul-16-18 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Apr-04-18 | Initiated | Leerink Partners | Outperform |
| Mar-06-18 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-06-18 | Reiterated | Needham | Buy |
| Mar-05-18 | Reiterated | BTIG Research | Buy |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Mar-13-17 | Reiterated | Needham | Buy |
| Dec-22-16 | Initiated | Piper Jaffray | Overweight |
| Nov-09-16 | Reiterated | Needham | Buy |
| Apr-05-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-11-16 | Upgrade | Needham | Hold → Buy |
View All
Vericel Corp Stock (VCEL) Latest News
Can Vericel Corporation stock sustain market leadershipStop Loss & Fast Momentum Entry Tips - newser.com
Can Vericel Corporation hit a new high this monthLayoff News & Community Verified Watchlist Alerts - newser.com
Geneva Capital Management LLC Acquires 419,183 Shares of Vericel Corporation $VCEL - MarketBeat
Vericel’s Pivotal Earnings Report Approaches - AD HOC NEWS
Heatmap analysis for Vericel Corporation and competitorsBuy Signal & Fast Moving Stock Watchlists - newser.com
Vericel (VCEL) to Release Quarterly Earnings on Thursday - MarketBeat
Strategies to average down on Vericel CorporationJuly 2025 News Drivers & Accurate Trade Setup Notifications - newser.com
InvestingPro’s fair value model correctly flagged Vericel’s 35% decline By Investing.com - Investing.com
Is Vericel Corporation stock attractive after correctionWeekly Stock Analysis & Safe Entry Trade Reports - fcp.pa.gov.br
Advanced analytics toolkit walkthrough for Vericel CorporationTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Measuring Vericel Corporation’s beta against major indices2025 Bull vs Bear & Safe Capital Growth Tips - newser.com
How Vericel Corporation (ATQP) stock reacts to fiscal policies2025 Major Catalysts & Fast Gain Swing Trade Alerts - newser.com
How Vericel Corporation stock performs in weak economyMarket Rally & Risk Managed Investment Strategies - newser.com
What dividend safety score for Vericel Corporation stockBull Run & Risk Managed Trade Strategies - newser.com
4,784 Shares in Vericel Corporation $VCEL Purchased by Vanguard Personalized Indexing Management LLC - Defense World
Vericel Corporation $VCEL Shares Bought by Kornitzer Capital Management Inc. KS - MarketBeat
Will Vericel Corporation (ATQP) stock beat revenue estimatesGap Down & Long-Term Investment Growth Plans - newser.com
Vericel (NASDAQ:VCEL) Given "Sell (D+)" Rating at Weiss Ratings - MarketBeat
Vericel Corp. Experiences Revision in Its Stock Evaluation Amid Complex Financial Landscape - Markets Mojo
Vericel showcases cell-based procedure at AOAO meeting - Traders Union
Vericel to Report Third-Quarter 2025 Financial Results on November 6, 2025 - The Manila Times
Vericel (NASDAQ:VCEL) to report Q3 2025; conference call and webcast on Nov. 6 - Stock Titan
Yousif Capital Management LLC Raises Stock Holdings in Vericel Corporation $VCEL - Defense World
What dividend safety rating applies to Vericel Corporation (ATQP) stockTrade Risk Report & Free High Return Stock Watch Alerts - newser.com
Here’s Why Vericel Corporation (VCEL) Underperformed in Q3 - Insider Monkey
Why Vericel Corporation (ATQP) stock fits value portfoliosJuly 2025 Macro Moves & Weekly Consistent Profit Watchlists - newser.com
Truist Lowers PT on Vericel Corporation (VCEL) to $41 From $46 - Insider Monkey
Will Vericel Corporation see short term momentumInsider Selling & Verified Entry Point Signals - newser.com
Vericel Corp Stock (VCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):